| Application no. and date | 21723520.9 (espacenet) (Federated) (European Patent Register), 20210413 | | Patent/reg. no. and date | DK/EP 4135690, 20260325 | | Publication date | 20230222 | | Priority no. and date | US 202063009595 P, 20200414, US 202063039722 P, 20200616 | | EP pub. no. and date |
EP 4135690 20230222 | | Effective date | | | Applicant/owner | Sumitomo Pharma America, Inc., 84 Waterford Drive
Marlborough, MA 01752, US | | Applicant ref. no. | V504326DK00 | | Inventor | HOPKINS, Seth Cabot, c/o Sunovion Pharmaceuticals Inc. 84 Waterford
Drive
Marlborough, Massachusetts 01752, US,
BOWEN, Carrie A., c/o Sunovion Pharmaceuticals Inc. 84 Waterford
Drive
Marlborough, Massachusetts 01752, US,
SYNAN, Colleen M., c/o Sunovion Pharmaceuticals Inc. 84 Waterford
Drive
Marlborough, Massachusetts 01752, US | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | A61K 31/381 (2006.01) , A61K 45/06 (2006.01) , A61P 25/00 (2006.01) , A61P 25/16 (2006.01) , A61P 25/18 (2006.01) , A61P 25/22 (2006.01) , A61P 25/28 (2006.01) , A61P 25/30 (2006.01) | | Title | (S)-(4,5-dihydro-7H-thieno[2,3-c]pyran-7-yl)-N-methylmethanamin til behandling, forebyggelse og/eller håndtering af en neurologisk og/eller psykiatrisk lidelse | | Int. application no. | US2021026953 | | Int. publication no. | WO2021211489 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
